22nd Century Group, Inc. filed its quarterly report on Form 10-Q with the SEC covering the period ended September 30, 2026, disclosing a net loss of $9.4 million for the nine months ended on that date and reporting 3,210,207 shares of common stock outstanding as of November 13, 2026.

Key Highlights

  • Net loss from continuing operations: $8,848 thousand for the nine months ended September 30, 2026, compared to $10,333 thousand in the same prior-year period.
  • Net revenues: $11,729 thousand for the nine months ended September 30, 2026, down from $14,050 thousand in the nine months ended September 30, 2025.
  • Q3 2026 revenues: $4,759 thousand for the three months ended September 30, 2026, up from $4,011 thousand in Q3 2025.
  • Total assets: $23,357 thousand at September 30, 2026, compared to $27,023 thousand at December 31, 2025.
  • Accumulated deficit: $408,325 thousand at September 30, 2026, versus $398,925 thousand at December 31, 2025.
  • Shares outstanding: 3,210,207 shares of common stock as of November 13, 2026, versus 391 thousand shares (as reported in thousands) at December 31, 2025.
  • Series A preferred shares: 0 shares issued and outstanding at September 30, 2026, down from 9,650 shares at December 31, 2025, with related mezzanine equity falling from $2,734 thousand to zero.

22nd Century Group Reports Q3 2026 Financial Position and Operating Results

22nd Century Group, Inc. (NASDAQ:XXII), a Nevada-incorporated company headquartered at 321 Farmington Road, Mocksville, North Carolina, filed its Form 10-Q for the quarterly period ended September 30, 2026. The company, which is classified as a non-accelerated filer and smaller reporting company, holds intangible assets of $5,638 thousand at the period end, reflecting its portfolio of plant science and tobacco-related intellectual property that underpins its operations.

According to the filing, net revenues for the nine months ended September 30, 2026 were $11,729 thousand, a decline from $14,050 thousand in the comparable prior-year period. For the three months ended September 30, 2026, however, revenues of $4,759 thousand exceeded the $4,011 thousand reported for Q3 2025. The company reported a gross profit of $446 thousand for Q3 2026, compared to a gross loss of $1,059 thousand in Q3 2025. For the nine-month period, the gross loss was $481 thousand, an improvement from a gross loss of $2,303 thousand in the same period of 2025, per the filing.

The filing discloses that total operating expenses for the nine months ended September 30, 2026 were $8,424 thousand, including sales, general and administrative costs of $7,272 thousand and research and development expenses of $813 thousand. The operating loss from continuing operations was $8,905 thousand for the nine-month period. Net loss available to common shareholders for the nine months ended September 30, 2026 was $35,320 thousand, which the filing indicates reflects deemed dividends of $18,134 thousand, a dividend for redemption of Series A Convertible Preferred Stock of $6,916 thousand, and a dividend for redemption of Series B Convertible Preferred Stock of $870 thousand. Cash and cash equivalents stood at $3,911 thousand at September 30, 2026, compared to $7,149 thousand at December 31, 2025.

What Was Disclosed

The Form 10-Q for the period ended September 30, 2026 discloses unaudited condensed consolidated financial statements, including balance sheet data showing total liabilities of $7,281 thousand and total shareholders' equity of $16,076 thousand. The filing also reports the full conversion of Series A preferred shares and the issuance of Series B convertible preferred shares during the nine-month period.